Motilal Oswal is the second brokerage house to initiate a coverage on Dr. Agarwal’s Healthcare. Last week, Morgan Stanley initiated coverage on the stock with an ‘Overweight’ rating and a price target of ₹502.
Motilal Oswal is the second brokerage house to initiate a coverage on Dr. Agarwal’s Healthcare. Last week, Morgan Stanley initiated coverage on the stock with an ‘Overweight’ rating and a price target of ₹502.